1. Adjusted D-dimer cutoff levels to rule out pulmonary embolism in patients hospitalized for COPD exacerbation: results from the SLICE trial.
- Author
-
Rodríguez, Carmen, Jara-Palomares, Luis, Tabernero, Eva, Tenes, Andrés, González, Sara, Briceño, Winnifer, Lobo, José Luis, Morillo, Raquel, Bikdeli, Behnood, and Jiménez, David
- Subjects
PULMONARY embolism ,PREDICTIVE tests ,VEINS ,AGE distribution ,HOSPITAL care ,OBSTRUCTIVE lung diseases ,THROMBOEMBOLISM ,DESCRIPTIVE statistics ,SENSITIVITY & specificity (Statistics) ,DIAGNOSTIC errors ,FIBRIN fibrinogen degradation products ,DISEASE exacerbation ,SECONDARY analysis - Abstract
Background: For patients with suspected pulmonary embolism (PE), age- or clinically-adjusted D-dimer threshold level can be used to define a negative test that safely excludes PE and reduces the use of imaging. However, the utility of this approach in patients hospitalized for chronic obstructive pulmonary disease (COPD) exacerbation is undefined. Methods: We ran an analysis of the patients hospitalized for COPD exacerbation and randomized to the intervention in the SLICE trial. Using the conventional strategy as the reference, we compared the proportion of patients with a negative D-dimer result, and the negative predictive value and sensitivity of three D-dimer threshold strategies for initial PE or subsequent diagnosis of venous thromboembolism (VTE): the age-adjusted strategy, the Wells-adjusted strategy, and the YEARS-adjusted strategy. Results: We included 368 patients. Using a conventional threshold, 182 (49.5%) patients had negative D-dimer values, of whom 1 (0.6%) had PE (sensitivity, 94.1%). The use of an age-adjusted threshold increased the number of patients in whom PE could be excluded from 182 to 233 patients (63.3%), and the proportion of false-negative findings increased from 0.5% to 1.7% (sensitivity, 76.5%). With the use of the Wells or YEARS strategies, 64.4% and 71.5% had negative values, and the proportion of false-negative findings was 2.5% (sensitivity, 64.7%) and 2.7% (sensitivity, 58.8%), respectively. Conclusions: In patients hospitalized for COPD exacerbation, compared with the conventional strategy, age- or clinically-adjusted strategies of D-dimer interpretation were associated with a larger proportion of patients in whom PE was ruled out with a higher failure rate. Trial Registration: ClinicalTrials.gov number: NCT02238639. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF